PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT
| PHARMANIAGA BERHAD |
| Type | Announcement |
| Subject | PRACTICE NOTE 17 / GUIDANCE NOTE 3 MONTHLY ANNOUNCEMENT |
| Description | PHARMANIAGA BERHAD (THE "COMPANY") - MONTHLY ANNOUNCEMENT PURSUANT TO PRACTICE NOTE 17 OF THE MAIN MARKET LISTING REQUIREMENTS OF BURSA MALAYSIA SECURITIES BERHAD |
|
Reference is made to the Company’s announcements dated 27 and 28 February 2023 (“First Announcement”). (Unless otherwise stated, the words and abbreviations used herein shall have the same meaning as those defined in the First Announcement.) The Board of Directors of the Company had on 30 November 2023 released its requisite announcement in relation to its regularisation plan. The Company is in the midst of preparing applications in relation to the proposed regularisation plan and has approximately two (2) months to submit the application to Bursa Securities for approval to implement the same. This announcement is dated 2 January 2024. |
|
Announcement Info
| Company Name | PHARMANIAGA BERHAD |
| Stock Name | PHARMA |
| Date Announced | 02 Jan 2024 |
| Category | General Announcement for PLC |
| Reference Number | GA1-02012024-00059 |